RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
 Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Research Article
Latest Research Channel

subscribe to Latest Research newsletter
Latest Research

   EMAIL   |   PRINT
The ESRF launches an ambitious Upgrade Program

Nov 25, 2008 - 5:00:00 AM
X-ray imaging: Revealing both the 3-D structure and the chemical composition of an object without altering it has countless applications in materials science, cultural heritage and engineering. The objective in this field is to resolve structures smaller than one micrometre.

 
[RxPG] More than ten thousand scientists across Europe will profit from new investments in the European Synchrotron Radiation Facility (ESRF) approved today. Over the next seven years, unique new experimental facilities for research with X-rays will come into operation. This decision, taken by the ESRF Council, representing the 19 countries financing the ESRF, confirms Europe's vision to expand its global leadership in photon science.

On 24-25 November 2008, the 50th Council meeting of the ESRF approved a 10% budget increase for 2009, to start a 177 million Euros Upgrade Programme over the next seven years (2009-2015). The main element of this programme is the development of new world-class experimental stations (beamlines) which will gradually enter into service as of 2011.

The ESRF Upgrade Programme builds on the fact that no other research infrastructure is growing faster than light sources: since 1994 when the ESRF was inaugurated, more than twenty new synchrotrons opened in Europe, the US and Asia. They produce cutting-edge science, illustrated by the publication of at least one paper on average in every single issue of Science and Nature in 2007. As much as 20% of this global scientific output originated at the ESRF and much of it is relevant to everyday life. Whether it relates to promising targets for a new drug, candidate materials for hydrogen storage in cars, dust grains collected in outer space or liquid-crystal photovoltaic cells, there is a high probability that such research includes experiments at the ESRF to determine structures and properties at the atomic scale with unequalled resolution and accuracy.

I am convinced that the Upgrade Programme will ensure the competitiveness of the ESRF for the benefit of Europe and European science says Professor Robert Feidenhans'l, Deputy Director of the Niels-Bohr Institute in Copenhagen and Chairman of the ESRF Council. The five key targets of the Upgrade Programme are:

Nanoscience and technology: Molecular machines, quantum dots or self-assembling 2-D crystals sound like magic words today but nanotechnology will be in tomorrow's consumer products. The future nanoscience beamlines at the ESRF are a foundation stone for such nano-engineering.

Structural biology and soft matter: Progress in health and life sciences is linked to understanding processes at the atomic scale. There is an explosion today in demand to resolve the structure of molecules for the development of new drugs. A new generation of automated experiments will screen about a thousand samples in a single day.

Ultrafast molecular processes: Studying a chemical reaction as it happens, like in a film, is possible today, but not at sufficient speed. Pushing the time-resolution into the picosecond (one trillionth of a second) regime will open new insight in chemical processing, catalysis and how proteins function in living cells.

Science at extreme conditions: Developing advanced materials, chemical processing and planetary science all need to put samples under extreme pressure, temperatures and magnetic fields. Whatever the extreme, the ESRF will strive to make it available in situ on one of its beamlines.

X-ray imaging: Revealing both the 3-D structure and the chemical composition of an object without altering it has countless applications in materials science, cultural heritage and engineering. The objective in this field is to resolve structures smaller than one micrometre.

It was a challenging task to satisfy the needs of a huge and varied scientific community from many countries, and even more challenging to strike a balance between ambition and affordability. I am very gratefull to our member countries. Despite a difficult funding context, they have given the green light for our Upgrade Programme, which will ensure a very bright future for the ESRF, says Professor Bill Stirling, Director General of the ESRF.




Advertise in this space for $10 per month. Contact us today.


Related Latest Research News


Subscribe to Latest Research Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)